Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Aug 14;15(8):e0237581. doi: 10.1371/journal.pone.0237581

Laryngopharyngeal reflux, gastroesophageal reflux and dental disorders: A systematic review

Jerome R Lechien 1,2,*, Carlos M Chiesa-Estomba 1,3, Christian Calvo Henriquez 1,4, Francois Mouawad 5, Cyrielle Ristagno 6, Maria Rosaria Barillari 1,7, Antonio Schindler 1,8, Andrea Nacci 1,9, Cyril Bouland 1,10, Luigi Laino 11, Sven Saussez 12,13
Editor: Giovanni Cammaroto14
PMCID: PMC7428125  PMID: 32797062

Abstract

Objectives

To investigate the role of gastroesophageal reflux disease (GERD) and laryngopharyngeal reflux (LPR) in the development of dental disorders.

Methods

The first outcome was review of the role of reflux in the development of dental disorders in adults. The second outcome was review of the potential pathophysiological mechanisms underlying the association between reflux and dental disorders. Three investigators screened publications for eligibility and exclusion based on predetermined criteria through a literature search conducted on PubMed, Cochrane Library, and Scopus according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).

Results

From 386 publications, 24 studies were kept for analysis. Objective approaches were used in 16 studies to confirm GERD diagnosis. Pharyngeal reflux episodes (LPR) were considered in 2 studies. No study considered nonacid reflux. The study results supported a higher prevalence of dental erosion and caries in reflux patients compared with healthy individuals. Patients with dental erosion have a higher prevalence of reflux than controls. The pathophysiological mechanisms would involve changes in the saliva physiology. No study investigated the microbiota modifications related to reflux although the findings are supporting the critical role of microbiota change in the development of dental disorders. There is an important heterogeneity between studies about diagnostic methods and clinical outcome evaluation.

Conclusion

The involvement of reflux in the development of dental disorders is not formally demonstrated and requires future investigations considering pharyngeal acid and nonacid reflux episodes and in particular their potential impact on oral microbiota.

Introduction

Laryngopharyngeal reflux (LPR) is an inflammatory condition of the upper aerodigestive tract tissues related to direct and indirect effect of gastroduodenal content reflux, which induces morphological changes in the upper aerodigestive tract [1]. The incidence of LPR-associated symptoms ranges from 10 to 30% of people of Western countries [2,3] and would be increasing concerning the changes in a modern lifestyle and dietary habits [4]. The LPR is involved in the development of many otolaryngological diseases through the deposit of gastroduodenal enzymes into the mucosa of the upper aerodigestive tract. Thus, pepsin has been identified in the laryngeal [5], hypopharyngeal [6], oral [7], nasal [7], tears [8], and Eustachian mucosa as well as in the secretion of chronic rhinosinusites [9] and chronic media otitis [10]. The involvement of reflux in the development of dental disorders has been suspected for several decades. Reflux would be responsible for increasing risk of oral mucosa inflammation [11], dental caries [11] and erosion [12]. Nowadays, the pathophysiological mechanisms underlying the development of dental disorders related to reflux are still poorly understood. Many hypotheses have been proposed including the reduction of the salivary buffering capacity or the modification of the pharyngeal/oral microbiota by acid reflux episodes [13].

The aim of this paper is to review the current literature about the role of reflux in the development of the following dental disorders: mucosa inflammation, dental erosion and caries.

Materials and methods

The criteria for considering studies for the systematic review were based on the population, intervention, comparison, and outcome (PICO) framework [14]. The review was conducted regarding the PRISMA checklist for systematic reviews [15].

Types of studies

The studies were included if they investigated the association between reflux and dental disorders (i.e., mucosa inflammation, dental erosion and caries) through clinical prospective, retrospective, randomized or non-randomized studies, or basic science research published in English or French in peer-reviewed journals. We considered the studies conducted in an adult population. Only studies reporting data for more than 10 patients were considered.

Participants, inclusion/exclusion criteria

Papers were included for analysis if they reported the diagnostic method for reflux disease (LPR or gastroesophageal reflux disease (GERD)). The clinical papers were included if the authors attempted a rigorous diagnosis of LPR or GERD through symptoms, findings, or objective testing. For GERD, the consideration of international criteria was appreciated (Johnson & DeMeester score [16]; Montreal criteria [17]). Patients with positive pH-monitoring or (hypopharyngeal-esophageal) multichannel intraluminal impedance-pH monitoring ((HE)MII-pH) were considered as LPR patients. Patients with reflux esophagitis or positive DeMeester score at the pH-study were considered as GERD patients. Patients with a clinical diagnosis of LPR or GERD without objective testing were considered as ‘suspected LPR or GERD patients’.

Outcomes

The main study outcome was a review of the potential causal association between reflux and the following dental disorders: mucosa inflammation, dental erosion and caries. Gingivitis and periodontitis were considered as mucosa inflammation disorders. The definitions and the tools used for the assessment of these dental disorders are available in Table 1 [1821]. Authors summarized the following characteristics of studies: the method/criteria used for the reflux diagnosis, the prevalence of dental disorders in the reflux population or the prevalence of reflux in the dental disorder population, the outcome used for the study of association between reflux and dental disorders, and the comparison of outcome with a control-group. The second study outcome was a review of the basic science studies for evaluating ways in which reflux might lead to dental disorders. Heterogeneity among included articles on patient population, means of reflux diagnosis, and outcomes measurements limited ability to combine data statistically into a formal meta-analysis, limiting analysis of the current Systematic Review to qualitative rather than a quantitative summary of the available information. The Tool to Assess Risk of Bias in Cohort Studies developed by the Clarity Group and Evidence Partners was used for the bias/heterogeneity analyses of the included studies [22].

Table 1. Definitions of dental disorders included in the present review.

Disorder Definition Assessment tools
Dental Erosion The loss of hard dental tissue by a chemical process without bacterial involvement. Tooth Wear Index (TWI)
Tooth decay (dental caries) The destruction of the outer surface (enamel) of a tooth. Decayed Missing Filled (DMF) Index
Gingivitis The non-destructive disease causing inflammation of the gums. Papillary Marginal Attached (PMA) Index
Periodontitis The chronic multifactorial inflammatory disease associated with dysbiotic plaque biofilms and characterized by progressive destruction of the tooth-supporting apparatus. PMA Index.

This table presents the scientific definitions of the dental disorders studied in the present review and the clinical scores used in the included papers for their assessment.18-21 All clinical score/index are characterized by a high score in pathological cases.

Intervention and comparison

Because the objective of this systematic review is to analyze the potential relationship between reflux and dental disorders, the included studies did not have to detail treatment approaches or response.

Search strategy

Three independent authors (JRL, CMCE and MRB) conducted a PubMed, Cochrane Library and Scopus search to identify articles published between January 1990 and December 2019 about the role of reflux in the development of dental disorders. There was a high degree of agreement between authors (p<0.05). Clinical and experimental studies were screened if they had database abstracts, available full-texts or titles referring to the condition. The following keywords were used: ‘reflux’; ‘laryngitis’; ‘laryngopharyngeal’; ‘gastroesophageal’; ‘dental’; ‘teeth’; ‘decay’; ‘caries’; ‘erosion’; and ‘mucosa’. Authors analyzed the number of patients, study design, inclusion and exclusion criteria, quality of trial and evidence level (EL).

Results

Initial screening identified 386 papers. Among these papers, 22 articles met our inclusion criteria and were kept for analysis (Fig 1, Table 2) [1113,2341]. Two additional basic research studies were included. These studies investigated the relationship between reflux, dental erosion [42,43] and mucosal inflammation [43].

Fig 1. Chart flow.

Fig 1

Table 2. Studies investigating the relationship between reflux and dental disorders.

References Design EL Patients characteristics Reflux diagnosis Outcome association Results Main findings
Meurman
[23]
Prospective B Gr1: 28 erosion + 1. GERD symptoms Ass. mucosal changes & Reflux - Patients with dental erosion have a higher score at the Maratka classification (reflux severity) compared with Individuals without erosion. There are no mucosal and saliva changes associated with reflux.
Controlled Gr2: 89 erosion - 2. In some patients: hygiene Gr1>Gr2
Gender: 78M/39F Single-probe pH study Saliva buffering capacity,
viscosity and flow rate.
Gr1 = Gr2
Age: 54–49 yo Johnson & DeMeester Gr1 = Gr2
Schroeder
[24]
Prospective B Gr1: 12 erosion + 1. GERD symptoms Prevalance GERD—LPR Gr1: N = 9 & 7 Patients with GERD or LPR at the dual-probe pH metry had a higher proportion of dental erosion. The propor- tion of dental erosion was particularly higher in LPR. There were no saliva disorders associated with reflux.
Controlled Gr2-3: 10 LPR-10 GERD 2. Dual-probe pH metry Saliva: pH, flow rates, buffering
capacity, Ca2+ & Phosphorus level
Gr1: N = 0
Gr4: 10 CT
Gender & Age: N.A. Dental erosion (Gr2, 3, 4) N = 7; 4; 1
Gudmundsson
[25]
Prospective C N = 14 erosion 1. Dual-probe pH metry Esophagitis GI endoscope (N = 12) N = 9 75% of patients with dental erosion and who benefited from GI endoscopy had esophagitis.
Uncontrolled Gender: 12M/2F
Age: 8–39 yo
Bartlett
[26]
Prospective B Gr1: 36 palatal erosion 1. GERD symptoms Distal reflux episodes N = 23 64% of patients with dental erosions had GERD at the pH monitoring (pH<4, 4% of time). Patients with acid pH in distal esophagus had lower oral pH. The acid oral pH was associated with a higher tooth wear index.
Controlled Gr2: 10 CT 2. Dual-probe pH metry Relation between:
Gender: N.A. Johnson & DeMeester Esophageal distal & oral pH +
Age: 15–74 yo TWI & acid oral pH +
Loffeld
[27]
Retrospective C N = 198 GERD 1. GERD symptoms Upper incisor damage (%) 32.5% GERD patients have a higher % of incisor damage. The duration of complaints was positively associated with the presence of upper incisor damage.
Gender: 118M/80F 2. Reflux esophagitis Lower incisor damage (%) 7.8%
Age: 17–93 yo Lower & upper incisor damage (%) 26.9%
Jarvinen
[28]
Prospective C Gr1: 20 esophagitis + 1. GERD symptoms Dental erosion prevalence (Gr1-2) N = 4; 0 20% of patients with esophagitis have dental erosion.
Uncontrolled Gr2: 48 esophagitis - 2. Reflux esophagitis
Gender & Age: N.A.
Gregory-Head
[29]
Prospective B Gr1: 10 GERD—Gr2: 10 CT 1. GERD symptoms TWI score GERD>CT Tooth wear index score was significantly higher in patients with GERD compared with patients with GERD-symptoms and no reflux at the pH monitoring.
Controlled Gender: N.A. 2. Dual-probe pH metry Mandibular surface involvement GERD>CT
Age: 18–69 yo Johnson & DeMeester Maxillary surface involvement GERD>CT
Munoz
[30]
Prospective B Gr1: 181 GERD 1. GERD symptoms Dental erosion prevalence GERD>CT The % and severity of dental erosion was higher in GERD patients compared with controls. There were no differences between groups about the periodontal status.
Controlled Gr2: 72 CT 2. GI endoscopy Periodontal statuts:
Gender: 71M/110F 3. Single-probe pH metry Plaque index, hemorrhagic index,
Gingival recessions
GERD = CT
Age: 48 yo GERD = CT
Moazez, 2005
[12]
Prospective B Gr1: 31 LPR—Gr2: 7 CT 1. LPR symptoms % of distal pH<4 LPR>CT The proportion of palatal tooth wear was higher in patients with a high number of pharyngeal reflux episodes compared with controls.
Controlled Gender: 19M/12F 2. Dual-probe pH metry % of pharyngeal pH<5.5 LPR>CT
Age: 43 yo Ass. tooth wear & objective LPR +
Oginni
[31]
Prospective B Gr1: 125 GERD 1. GERD symptoms Impaired TWIs & Gr differences Dental erosion is significantly more prevalent in GERD patients compared with CT.
Controlled Gr2: 100 CT 2. Reflux esophagitis GERD patients 16%; GERD>CT
Gender: 57M/68F CTs 5%
Age: 38 yo
Holbrook
[32]
Prospective C N = 91 erosion & GERD 1. GERD symptoms Low salivary buffering 10.4% 10% of suspected GERD patients had low salivary buffering capacity, which was associated with dental erosion.
Uncontrolled symptoms Ass. LSB & erosion +
Gender & Age: N.A. Low esophageal pH 17.7%
Filipi
[33]
Prospective C N = 24 GERD 1. GERD symptoms Buffering capacity reduction N = 13 Patients with a long history of GERD had a higher risk of caries and erosions compared with short GERD history patients. 54% had buffering capacity disorder.
Uncontrolled Gender: 7M/17F 2. Single-probe pH metry Caries & erosion prevalences long GERD history>
short GERD history
Age: 46 yo Johnson & DeMeester
Correa
[13]
Prospective B Gr1 = 30 GERD—Gr2 = 30 CT 1. LPR symptoms Dental erosion number & severity GERD>CT GERD patients have a higher number (and severity) of dental erosion than CT. The saliva buffering capacity is abnormal in GERD patients.
Controlled Gender: 10M/20F 2. Single-probe pH metry Saliva buffering capacity CT>GERD
Age: 33 yo 3. GI endoscopy
Yoshikawa
[34]
Prospective B Gr1 = 40 GERD 1. GERD symptoms Decayed missing filled index GERD>CT Oral symptoms in GERD are likely to be associated with impaired salivary flow volume. GERD patients have a higher number of decay, erosion, and gingival disorders compared with CT.
Controlled Gr2 = 30 CT Montreal criteria Papillary, marginal, attached index GERD>CT
Gender: 21M/19F Oral Hygiene Index GERD>CT
Age: 69 yo Dental erosion prevalence (GERD) 24.3%
Salivary flow volume CT>GERD
Song
[35]
Retrospective B Gr1 = 280 periodontis 1. GERD symptoms Ass. GERD & Periodontis + GERD is a risk factor for developing caries and chronic periodontis.
Gr2 = 280 CT Montreal criteria Ass. GERD & caries +
Gender: 140M/140F
Age: 49 yo
Alavi
[36]
Prospective B Gr1 = 31 GERD—Gr2 = 71 CT 1. GERD symptoms GERD dental erosion prevalence 22.6% 22.6% of GERD patients had dental erosion, which was significantly higher compared with CT.
Controlled Gender: N.A. 2. Reflux esophagitis CT dental erosion prevalence 7%
Age: 30–50 yo Comparison GERD vs CT GERD>CT
Deppe
[37]
Prospective C N = 71 GERD/NERD 1. GERD symptoms Oral mucosa erythema/ulcer N = 19 (27%)–0 (0%) 27% of GERD patients have oral mucosa acidic irritation.
Uncontrolled Gender: 30M/41F 2. Reflux esophagitis Acidic palatal mucosa lesions N = 10 (14%)
Age: 50 yo Acidic tongue mucosa lesions N = 4 (6%)
Wilder-Smith,
[38]
Prospective C N = 374 erosion + 1. GERD symptoms MII-pH GERD prevalence 69% 69% of patients with dental erosion had GERD at the MII-pH. There was no significant association between reflux characteristics and dental erosion severity.
Uncontrolled Gender: 222M/127F 2. Acid reflux (MII-pH)
Age: 35 yo
Vinesh
[39]
Prospective C N = 142 GERD 1. GERD symptoms Dental erosion (%) 44.0% Dental erosion, periodontitis and gingivitis are the most prevalent dental disorders found in GERD patients.
Uncontrolled Gender: N.A. Periodontis (%) 25.5%
Age: N.A. Gingivitis—gingival ulcer (%) 9.9%–2%
Gingival or palatal erythema (%) 5.7%–2.8%
Mouth floor erythema (%) 1.4%
Milani
[40]
Prospective B Gr1 = 143 GERD 1. GERD symptoms GERD dental erosion prevalence 25.9% GERD patients had a higher prevalence of dental erosion compared with CT.
Controlled Gr2 = 274 CT CT dental erosion prevalence 17.2%
Gender: 43M/100F Comparison GERD vs CT GERD>CT
Age: 43 yo
Watanabe
[11]
Retrospective C Gr1 = 105 GERD 1. GERD symptoms Salivary flow volume CT>GERD Oral soft tissue disorders, dental erosions and caries are associated with GERD.
Gr2 = 50 NER 2. GI endoscopy: PMA Index scores GERD>CT
Gender: 57M/48F Gr1: reflux esophagitis OHI-S GERD>CT
Age: 66 yo Gr2: non-erosive reflux Decay indices GERD>CT
Warsi
[41]
Prospective C N = 187 GERD 1. GERD symptoms Oral submucous fibrosis (%) 66.3% 35.3% of GERD patients have dental erosion. Nausea, vomitting, esophagitis, xerostomia, ulcer, gingivitis, & angular cheilitis were associated with GERD.
Uncontrolled Gender: 109M/78F 2. GI endoscopy Oral ulceration (%) 59.4%
Age: N.A. 3. Reflux esophagitis Dental erosion prevalence (%) 35.3%

Abbreviations: Ass. = association; CT = control(s); EL = evidence level; GERD (s) = gastroesophageal reflux disease (symptoms); GI = gastrointestinal; Gr = group; LPR = laryngopharyngeal reflux; LSB = low salivary buffering; M/F = male/female; MII-pH = multichannel intraluminal impedance pH-monitoring; N.A. = not available; NER = non-erosive reflux; OHI-S = Simplified Oral Hygiene Indice; PMA = Papillary Marginal Attached; TWIs = tooth wear index score; yo = years old.

Reflux and dental erosion

Dental erosion in reflux patients

A total of 18 papers investigated the relationship between reflux and dental erosion in patients with a suspected or confirmed diagnosis of reflux [13,2334,36,3841]. The prevalence of dental erosion in reflux patients ranged from 16% to 44%, [27,28,31,34,36,3941] whereas dental erosion occurred in <20% of healthy individuals [31,36,40]. Overall, controlled studies showed that GERD patients have a significantly higher rate or severity score of dental erosion compared with healthy individuals (Table 2) [13,2931,36,40].

According to dual-probe esophageal pH testing, Schroeder et al. found a higher prevalence of dental erosion in LPR patients (N = 7/10; 70%) compared with GERD patients (N = 3/10; 30%) or controls (N = 1/10; 10%) [24]. In the same vein, Moazez et al. reported that patients with pharyngeal acid or weakly acid reflux episodes had higher tooth wear index scores than healthy individuals [12].

About the location of erosions, Gregory-Head et al. found that reflux was associated with the development of dental erosion in both mandibular and maxillary surfaces [29]. However, the results of the study of Loffeld et al. suggested a differential impact of reflux on the tooth damage [27]. Thus, the rate of upper incisor damage (32.5%) was higher than the rate of lower incisor damage (7.8%) in patients with positive GERD regarding Johnson & DeMeester score. These authors also reported that the duration of GERD complaints was positively associated with the presence of upper incisor damage [27]. Similar findings have been suggested by Filipi et al., who observed that a long GERD history was significantly associated with a higher risk of caries and dental erosion [33].

Reflux in patients with dental erosion

Four studies focused on the prevalence of reflux in patients with dental erosion [23,25,26,38]. The prevalence of GERD-symptoms or findings (esophagitis or positive pH testing) in patients with dental erosion ranged from 64% to 75% [25,26,38]. Bartlett et al. found that 64% of patients with dental erosion had pathological distal reflux regarding Johnson & DeMeester score [26]. Moreover, they reported that GERD patients with oral acid pH had higher tooth wear index scores. In the same vein, Meurman et al. reported that the severity of dental erosion was higher in patients with suspected or confirmed GERD compared with subjects with dental erosion but no GERD [23]. More recently, Wilder-Smith et al. did not report a significant association between the characteristics of the distal reflux episodes (acid or weakly acid) and the severity of dental erosion [38].

Reflux, caries and oral mucosa disorders

Three studies investigated the relationship between reflux and caries in adults [11,34,35]. Initially, Yoshikawa et al. observed higher scores of decayed missing filled index in GERD patients compared with controls [34]. Two years later, Song et al. retrospectively supported the positive association between the presence of GERD symptoms and the development of both periodontitis and caries [35]. The results of these two studies were corroborated in the controlled study of Watanabe et al., who found stronger scores of decay indices in GERD patients compared with healthy subjects [11].

The involvement of reflux in the development of both gingival and periodontal disorders has been studied in 5 studies [11,30,37,39,41]. Munoz et al. did not find significant differences between patients with positive esophageal pH testing and healthy individuals in the periodontal status, including plaque index, hemorrhagic index, and gingival recessions [30]. More recently, Vinesh et al. reported a periodontitis rate of 25.5% in GERD patients [39]. In the same study, the authors reported that <10% of GERD patients had oral mucosa or gingival inflammation findings (erythema, ulcer) [39]. These results did not corroborate those of Yoshikawa et al. and Watanabe et al. who reported more frequently mucosa inflammatory findings (papillary, marginal, attached index) in GERD patients compared with controls [11,34].

Other mucosal changes have been reported in the study of Deppe et al. where 27% of GERD or non-erosive reflux patients had findings suggesting oral irritation (e.g. palatal, buccal and tongue erythema) [37]. The proportion of reflux patients affected by oral mucosal changes was higher in the study of Warsi et al.: these authors found that 66.3% and 59.4% of GERD patients had oral submucous fibrosis and oral ulceration(s), respectively [41].

Potential mechanisms of association

Clinical studies

The impact of reflux on the saliva physiology is the most studied field for explaining the relationship between reflux, dental erosion, caries and mucosa inflammation [11,13,23,3234]. The occurrence of lower salivary buffering capacity in GERD patients has been supported in three studies [14,32,33]. Among the other saliva impairments, studies supported that the low oral pH [32] and the low salivary flow rate [11,34] may be additional factors contributing to the development of dental erosion in GERD patients. Moreover, two studies reported that the oral hygiene index was better in healthy individuals compared with GERD patients [11,34].

Experimental research

Higo et al. explored the association between dental erosion and GERD in a surgically induced reflux rat model [42]. They observed a significant higher rate of dental erosion, alveolar bone destruction and osteomyelitis in reflux rats compared with controls 30 weeks after the surgery. In a similar rat model, Shimazu et al. investigated the development of dental and oropharyngeal lesions [43], in particular pathological changes in the tooth and pharynx on experimental rat model of chronic acid GERD, elucidating the possible association between gastric acid reflux and oral and pharyngeal diseases. The oral cavities were observed histologically every 2 weeks until 20 weeks and the results reported a shorter molar crown heights in GERD rats with dental erosion (10-weeks after) and dentin exposure (20-weeks after), associated with inflammatory cell infiltration of neutrophils and lymphocytes and fibrosis both in the periodontal pocket and in the posterior part of the tongue mucosa.

Epidemiological analysis

The vast majority of the studies were controlled studies. Overall, 11 studies were prospective controlled (EL: B), 8 were prospective uncontrolled (EL: C), and 3 were retrospective chart reviews (EL: C). There was an important heterogeneity between studies about the reflux diagnosis approaches. The reflux diagnosis consisted of GERD symptoms ± objective examination(s) in the majority of studies (N = 20).

The reflux diagnosis was based on GERD symptoms and demonstrated reflux esophagitis (N = 7) [11,27,28,31,36,37,41]; GERD symptoms only (N = 5) [32,34,35,39,40]; two other groups using Montreal criteria) [34,35]; or GERD symptoms and positive findings at the single- [30,33] or dual-probe pH monitoring (N = 5) [24,26,29]. Among the authors using the pH monitoring for the diagnosis, 4 authors used Johnson & DeMeester criteria [23,26,29,33], whereas other used composite criteria or did not provide the detailed information for the GERD diagnosis [12,13,24,25,30,38]. Among the composite approaches, Meurman et al. recognized using single-probe pH monitoring in some patients of the cohort; the diagnosis of other patients being based on GERD symptoms only [23]. Correa et al. included patients with both GERD and LPR symptoms, but the diagnosis confirmation was based on the positive distal acid reflux episodes at the single-probe esophageal pH monitoring [13]. Wilder-Smith et al. considered acid and weakly acid reflux episodes through MII-pH findings in patients with GERD symptoms [38]. The detection of acid pharyngeal reflux episodes was considered for the diagnosis of LPR in 2 studies [12,25]. Many authors did not exclude cofactors that may lead to dental disorders, such as bruxism, alcohol or tobacco consumption, medication, radiation and history of dental procedures. The bias analysis is reported in Table 3. For the LPR diagnosis, the following criteria/ratings were considered for the analysis: No = authors based the diagnosis on symptoms or findings only; Probably no = authors based the diagnosis on single probe esophageal pH monitoring or esophagitis; Probably yes = authors based the diagnosis on dual/triple esophageal/pharyngeal probe pH monitoring or pepsin detection in tissue; Yes = authors based the diagnosis on impedance pH monitoring considering acid/nonacid pharyngeal reflux episodes. For the exclusion criteria/confounding factors, the following criteria/ratings were considered for the analysis: No = many conditions were not excluded and the risk of bias in the study results is high; Probably no = some conditions were not excluded and the risk of bias in the study results may be significant; Probably yes = the majority of confounding conditions were excluded and the risk of bias in the study results may be low; Yes = authors carefully excluded the majority of confounding conditions that may bias the interpretation of the study results. For the outcome of association, the following criteria/ratings were considered for the analysis: No = outcomes are not adequate to demonstrate potential association; Probably no = outcomes are less adequate to demonstrate potential association; probably yes = outcomes may be adequate to demonstrate potential association; yes = outcomes are adequate to demonstrate potential association.

Table 3. Bias analysis.

References LPR diagnosis Cofactors Outcomes of association
Meurman [23] Probably no Probably yes Probably yes
Schroeder [24] Probably yes Yes Probably yes
Gudmundsson [25] Probably yes N.A. No
Bartlett [26] Probably yes Probably no Probably no
Loffeld [27] Probably no N.A. Probably no
Jarvinen [28] Probably no N.A. Probably no
Gregory-Head [29] Probably yes Probably yes Probably yes
Munoz [30] Probably no Probably yes Probably yes
Moazez, 2005 Probably yes N.A. Probably yes
Oginni [31] Probably no Probably no Probably no
Holbrook [32] No Probably yes Probably no
Filipi [33] Probably no N.A. Probably no
Correa [13] Probably no Probably no Probably no
Yoshikawa [34] No Probably no Probably yes
Song [35] No Probably no Probably no
Alavi [36] Probably no N.A. No
Deppe [37] Probably no Probably no Probably no
Wilder-Smith [38] Probably yes Yes Probably yes
Vinesh [39] No N.A. Probably no
Milani [40] No Probably yes No
Watanabe [11] Probably no Probably yes Probably yes
Warsi [41] Probably no Probably no Probably no

The Tool to Assess Risk of Bias in Cohort Studies developed by the Clarity Group and Evidence Partners was used for the bias/heterogeneity analyses of the included studies.22 Abbreviations: N.A. = not available.

Discussion

Direct and indirect treatment costs due to dental diseases worldwide are estimated from $144 to $442 billion yearly, corresponding to an average of 4.6% of global health expenditure [44]. Dental erosion and caries are among the most prevalent dental diseases, the latter affecting more than 2.5 billion people worldwide [45]. In that context, the identification of favoring factors, such as reflux, makes particularly sense to reduce the considerable economic burden to society related to the management of these disorders.

The main finding of this review is the identification of an important heterogeneity between studies in the method used for the reflux diagnosis. Thus, the large majority of studies considered the reflux diagnosis through GERD criteria (GERD symptoms, reflux esophagitis, esophageal distal reflux episodes) and only two studies really distinguished LPR from GERD [12,25]. Nowadays, there is no consensus about the LPR diagnosis criteria, but many authors agree that LPR may be highly suspected in case of laryngopharyngeal symptoms, findings and ≥1 acid or nonacid pharyngeal reflux episodes at the 24-hour HEMII-pH [4648]. In the majority of studies, the authors did not investigate the occurrence of pharyngeal reflux episodes and did not consider nonacid reflux, which concerns more than 50% of LPR patients [47,48]. The only consideration of reflux diagnosis though GERD criteria is a selection bias because heartburn and other GERD-associated digestive complaints are not present in all LPR patients, and less than 50% of GERD patients have LPR regarding the HEMII-pH [1,49]. For this reason, it is still difficult to drawn a clear conclusion about the impact of LPR in the development of dental disorders. We can state that the prevalence of dental erosion and (to a lesser extent) caries appears to be higher in GERD patients compared with healthy individuals.

The heterogeneity in the patient inclusion criteria may explain the inconsistencies between studies, particularly in the assessment of salivary function. Indeed, some authors identified a significant rate of impaired salivary function in GERD patients [13,32,33], while Meurman et al. did not find significant abnormalities [23]. The lack of consideration of pharyngeal reflux episodes is particularly problematic for the analysis of saliva function because to have an impact on the saliva secretion and composition. Reflux has to be characterized by pharyngeal/oral reflux episodes. The current controversial results found in the literature are probably due to the study of different profiles of patients; some patients having GERD and LPR other subjects having GERD without LPR.

However, the study of the modifications of the saliva function makes sense in the reflux context. Saliva is composed of many protective factors (e.g. epidermal growth factor, mucus, bicarbonate), which are modified by LPR [5052]. For example, some works have demonstrated that pepsin negatively impacts the function of carbonic anhydrase type III, which is an essential enzyme for the production of bicarbonate in the pharyngolaryngeal mucosa [53]. Besides, Samuels et al. reported that pepsin might impair the expression of different mucin genes, leading to dehydration of the mucus, which becomes less protective [54]. In the same way, LPR is associated with a decrease of epidermal growth factor in the saliva, which may decrease the healing of mucosal lesions [52]. According to these observations and the results of the studies included in the present review, it is reasonable to suspect that reflux may lead to saliva impairments, which may involve flow rate and buffering capacity. The modification of saliva composition and secretion could be associated with a decrease in the dental hygiene status of reflux patients, which is supported in two studies [23,34].

Dental erosion may be related to other etiologies than LPR, including bruxism [55], extrinsic acids (fruit juices, carbonated and isotonic drinks) [56], medication [57], eating disorders [57], alochol and tobacco [30], radiation and history of dental procedures [58]. The epidemiological analysis found that a significant number of authors did not consider these confounding factors in their studies, leading to potential biases.

Strangely, there is an important expanding research area that has not been explored in patients with both reflux and dental disorders: the laryngopharyngeal and oral microbiota. The study of the microbiota is an expanding area in many digestive diseases because it would be associated with the development and the therapeutic response of some inflammatory diseases [59]. In oral and dental disorders, recent studies reported the protective role of some bacteria such as Akkermansia muciniphila against the development of periodontal disorders in animal models [60]. Another recent paper supported the pivotal role of oral microbiota in regulating human oral health [61]. According to the characteristics of oral microbiota, some patients would develop more frequently caries than others, due to complex interaction between the commensal microbiota, host susceptibility and environmental factors [62]. Because LPR is associated with laryngopharyngeal and oral pH changes [25,63] and involves the reflux of many digestive enzymes, it is conceivable that the reflux disease may change the local microbiota, which could be associated with modulation of the local inflammation. In the same vein, the consumption of proton pump inhibitors (PPI) is known to be associated with oral microbiota changes [64,65]. Note that, to date, only one study investigated the dental health of GERD patients throughout a PPI clinical course. Wilder-Smith et al. found that erosive tooth wear did not progress over the 12-month PPI course [66]. The microbiota of patients with laryngeal carcinoma seems to be modified [67]. To our knowledge, there is no study extensively investigating this field of research. Only two studies suggested potential modification of the prevalence of Streptococcus mutans in GERD children [68], but they did not investigate the other commensal microorganisms. Naturally, it is currently impossible to state that LPR induces microbiota changes, but this hypothesis has to be investigated in future experimental and clinical studies. Moreover, the future studies could consider the role of diet in both the oral microbiota changes and the development of reflux. Indeed, both exogenous acids (from the diet) and endogenous acids (from stomach juice) are known to dissolve the enamel mineral, resulting in dental erosions [69].

Conclusion

The involvement of reflux in the development of dental erosion, caries, and mucosa inflammation is not demonstrated. The lack of use of HEMII-pH, the heterogeneity between studies, and the low level of evidence of studies limit the drawn of clear conclusion. Future clinical controlled studies should consider all types of laryngopharyngeal reflux, the detection of gastroduodenal proteins in the saliva and the potential interaction between diet, reflux and oral microbiota. The future demonstration of relationship between LPR and oral disorders makes sense regarding the prevalence of both patients with a long history of reflux and dental disorders.

Supporting information

S1 Checklist. PRISMA 2009 checklist.

(DOC)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Lechien JR, Akst LM, Hamdan AL, et al. Evaluation and Management of Laryngopharyngeal Reflux Disease: State of the Art Review. Otolaryngol Head Neck Surg. 2019. May;160(5):762–782. 10.1177/0194599819827488 [DOI] [PubMed] [Google Scholar]
  • 2.Kamani T, Penney S, Mitra I, Pothula V. The prevalence of laryngopharyngeal reflux in the English population. Eur Arch Otorhinolaryngol. 2012; 269(10):2219–25. 10.1007/s00405-012-2028-1 [DOI] [PubMed] [Google Scholar]
  • 3.Spantideas N, Drosou E, Bougea A, Assimakopoulos D. Laryngopharyngeal reflux disease in the Greek general population, prevalence and risk factors. BMC Ear Nose Throat Disord. 2015; 15:7 10.1186/s12901-015-0020-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Lechien JR, Bobin F, Muls V, Horoi M, Thill MP, Dequanter D, et al. Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring. Eur Arch Otorhinolaryngol. 2019. 10.1007/s00405-019-05711-2 [DOI] [PubMed] [Google Scholar]
  • 5.Samuels TL, Handler E, Syring ML, et al. Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. Ann Otol Rhinol Laryngol. 2008; 117(9):688–95. 10.1177/000348940811700911 [DOI] [PubMed] [Google Scholar]
  • 6.Johnston N, Wells CW, Samuels TL, Blumin JH. Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells. Ann Otol Rhinol Laryngol. 2009; 118(9):677–85. 10.1177/000348940911800913 [DOI] [PubMed] [Google Scholar]
  • 7.Sereg-Bahar M, Jerin A, Jansa R, Stabuc B, Hocevar-Boltezar I. Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux—a prospective comparative study. Clin Otolaryngol. 2015; 40(3):234–9. 10.1111/coa.12358 [DOI] [PubMed] [Google Scholar]
  • 8.Iannella G, Di Nardo G, Plateroti R, Rossi P, Plateroti AM, Mariani P, et al. Investigation of pepsin in tears of children with laryngopharyngeal reflux disease. Int J Pediatr Otorhinolaryngol. 2015; 79(12):2312–5. 10.1016/j.ijporl.2015.10.034 [DOI] [PubMed] [Google Scholar]
  • 9.Ren JJ, Zhao Y, Wang J, Ren X, Xu Y, Tang W, et al. PepsinA as a Marker of Laryngopharyngeal Reflux Detected in Chronic Rhinosinusitis Patients. Otolaryngol Head Neck Surg. 2017; 156(5):893–900. 10.1177/0194599817697055 [DOI] [PubMed] [Google Scholar]
  • 10.Formánek M, Zeleník K, Komínek P, Matoušek P. Diagnosis of extraesophageal reflux in children with chronic otitis media with effusion using Peptest. Int J Pediatr Otorhinolaryngol. 2015; 79(5):677–9. 10.1016/j.ijporl.2015.02.013 [DOI] [PubMed] [Google Scholar]
  • 11.Watanabe M, Nakatani E, Yoshikawa H, et al. Oral soft tissue disorders are associated with gastroesophageal reflux disease: retrospective study. BMC Gastroenterol. 2017; 17(1):92 10.1186/s12876-017-0650-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Moazzez R, Bartlett D, Anggiansah A. Dental erosion, gastro-oesophageal reflux disease and saliva: how are they related? J Dent 2004; 32: 489–94. 
 10.1016/j.jdent.2004.03.004 [DOI] [PubMed] [Google Scholar]
  • 13.Corrêa MC, Lerco MM, de Cunha ML, Henry MA. Salivary parameters and teeth erosions in patients with gastroesophageal reflux disease. Arq Gastroenterol. 2012; 49(3):214–8. 10.1590/s0004-28032012000300009 [DOI] [PubMed] [Google Scholar]
  • 14.Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak. 2007;7:16 10.1186/1472-6947-7-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.McInnes MDF, Moher D, Thombs BD, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA. 2018;319(4):388–396. 10.1001/jama.2017.19163 [DOI] [PubMed] [Google Scholar]
  • 16.Johnson LF, DeMeester TR. Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol. 1986;8 Suppl 1:52–8. [DOI] [PubMed] [Google Scholar]
  • 17.Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006; 101(8):1900–20; quiz 1943. 10.1111/j.1572-0241.2006.00630.x [DOI] [PubMed] [Google Scholar]
  • 18.Smith BG, Knight JK. An index for measuring the wear of teeth. Br Dent J. 1984;156:435–8. 10.1038/sj.bdj.4805394 [DOI] [PubMed] [Google Scholar]
  • 19.Eslamipour F, Borzabadi-Farahani A, Asgari I. The relationship between aging and oral health inequalities assessed by the DMFT index. Eur J Paediatr Dent. 2010;11:193–9. [PubMed] [Google Scholar]
  • 20.Papapanou PN, Sanz M, Buduneli N, et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018; 89 Suppl 1:S173–S182. [DOI] [PubMed] [Google Scholar]
  • 21.Wei SH, Lang KP. Periodontal epidemiological indices for children and adolescents: I. gingival and periodontal health assessments. Pediatr Dent. 1981;3:353–60. [PubMed] [Google Scholar]
  • 22.Viswanathan M, Berkman ND, Dryden DM, Hartling L. Assessing Risk of Bias and Confounding in Observational Studies of Interventions or Exposures: Further Development of the RTI Item Bank. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013. http://www.ncbi.nlm.nih.gov/books/NBK154461/. Accessed October 20, 2019. [PubMed] [Google Scholar]
  • 23.Meurman JH, Toskala J, Nuutinen P, Klemetti E. Oral and dental manifestations in gastroesophageal reflux disease. Oral Surg Oral Med Oral Pathol 1994; 78: 583–9. 
 10.1016/0030-4220(94)90168-6 [DOI] [PubMed] [Google Scholar]
  • 24.Schroeder PL, Filler SJ, Ramirez B, Lazarchik DA, Vaezi MF, Richter JE. Dental erosion and acid reflux disease. Ann Intern Med 1995; 122: 809–15. 10.7326/0003-4819-122-11-199506010-00001 [DOI] [PubMed] [Google Scholar]
  • 25.Gudmundsson K, Kristleifsson G, Theodors A, Holbrook WP. Tooth erosion, gastroesophageal reflux, and salivary buffer capacity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995; 79(2):185–9. 10.1016/s1079-2104(05)80280-x [DOI] [PubMed] [Google Scholar]
  • 26.Bartlett DW, Evans DF, Anggiansah A, Smith BG. A study of the association between gastro-oesophageal reflux and palatal dental erosion. Br Dent J 1996; 181: 125–31. 
 10.1038/sj.bdj.4809187 [DOI] [PubMed] [Google Scholar]
  • 27.Loffeld RJ. Incisor teeth status in patients with reflux oesophagitis. Digestion 1996; 57: 388–90. 10.1159/000201365 [DOI] [PubMed] [Google Scholar]
  • 28.Jarvinen V, Meurman JH, Hyvarinen H, Rytomaa I, Murtomaa H. Dental erosion and upper gastrointestinal disorders. Oral Surg Oral Med Oral Pathol 1988; 65: 298–303. 10.1016/0030-4220(88)90113-2 [DOI] [PubMed] [Google Scholar]
  • 29.Gregory-Head BL, Curtis DA, Kim L, Cello J. Evaluation of dental erosion in patients with Gastroesophageal reflux disease. J Prosthet Dent 2000; 83: 675–80. [PubMed] [Google Scholar]
  • 30.Munoz JV, Herreros B, Sanchiz V, et al. Dental and periodontal lesions in patients with gastro-oesophageal reflux disease. Dig Liver Dis 2003; 35: 461–7. 10.1016/s1590-8658(03)00215-9 [DOI] [PubMed] [Google Scholar]
  • 31.Oginni AO, Agbakwuru EA, Ndububa DA. The prevalence of dental erosion in Nigerian patients with gastro-oesophageal reflux disease. BMC Oral Health 2005; 5: 1 10.1186/1472-6831-5-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Holbrook WP, Furuholm J, Gudmundsson K, Theodórs A, Meurman JH. Gastric reflux is a significant causative factor of tooth erosion. J Dent Res. 2009; 88(5):422–6. 10.1177/0022034509336530 [DOI] [PubMed] [Google Scholar]
  • 33.Filipi K, Halackova Z, Filipi V. Oral health status, salivary factors and microbial analysis in patients with active gastro-oesophageal reflux disease. Int Dent J. 2011; 61(4):231–7. 10.1111/j.1875-595X.2011.00063.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Yoshikawa H, Furuta K, Ueno M, et al. Oral symptoms including dental erosion in gastroesophageal reflux disease are associated with decreased salivary flow volume and swallowing function. J Gastroenterol. 2012; 47(4):412–20. 10.1007/s00535-011-0515-6 [DOI] [PubMed] [Google Scholar]
  • 35.Song JY, Kim HH, Cho EJ, Kim TY. The relationship between gastroesophageal reflux disease and chronic periodontitis. Gut Liver. 2014; 8(1):35–40. 10.5009/gnl.2014.8.1.35 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Alavi G, Alavi A, Saberfiroozi M, Sarbazi A, Motamedi M, Hamedani Sh. Dental Erosion in Patients with Gastroesophageal Reflux Disease (GERD) in a Sample of Patients Referred to the Motahari Clinic, Shiraz, Iran. J Dent (Shiraz). 2014; 15(1):33–8. [PMC free article] [PubMed] [Google Scholar]
  • 37.Deppe H, Mücke T, Wagenpfeil S, Kesting M, Rozej A, Bajbouj M, et al. Erosive esophageal reflux vs. non erosive esophageal reflux: oral findings in 71 patients. BMC Oral Health. 2015; 15:84 10.1186/s12903-015-0069-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Wilder-Smith CH, Materna A, Martig L, Lussi A. Gastro-oesophageal reflux is common in oligosymptomatic patients with dental erosion: A pH-impedance and endoscopic study. United European Gastroenterol J. 2015; 3(2):174–81. 10.1177/2050640614550852 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Vinesh E, Masthan K, Kumar MS, Jeyapriya SM, Babu A, Thinakaran M. A Clinicopathologic Study of Oral Changes in Gastroesophageal Reflux Disease, Gastritis, and Ulcerative Colitis. J Contemp Dent Pract. 2016; 17(11):943–947. 10.5005/jp-journals-10024-1959 [DOI] [PubMed] [Google Scholar]
  • 40.Milani DC, Venturini AP, Callegari-Jacques SM, Fornari F. Gastro-oesophageal reflux disease and dental erosions in adults: influence of acidified food intake and impact on quality of life. Eur J Gastroenterol Hepatol. 2016;28(7):797–801. 10.1097/MEG.0000000000000622 [DOI] [PubMed] [Google Scholar]
  • 41.Warsi I, Ahmed J, Younus A, Rasheed A, Akhtar TS, Ain QU, et al. Risk factors associated with oral manifestations and oral health impact of gastro-oesophageal refluxdisease: a multicentre, cross-sectional study in Pakistan. BMJ Open. 2019; 9(3):e021458 10.1136/bmjopen-2017-021458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Higo T, Mukaisho K, Ling ZQ, Oue K, Chen KH, Araki Y, et al. An animal model of intrinsic dental erosion caused by gastro-oesophageal reflux disease. Oral Dis. 2009; 15(5):360–5. 10.1111/j.1601-0825.2009.01561.x [DOI] [PubMed] [Google Scholar]
  • 43.Shimazu R, Yamamoto M, Minesaki A, Kuratomi Y. Dental and oropharyngeal lesions in rats with chronic acid reflux esophagitis. Auris Nasus Larynx. 2018; 45(3):522–526. 10.1016/j.anl.2017.08.011 [DOI] [PubMed] [Google Scholar]
  • 44.Listl S, Galloway J, Mossey PA, Marcenes W. Global Economic Impact of Dental Diseases. J Dent Res. 2015; 94(10):1355–61. 10.1177/0022034515602879 [DOI] [PubMed] [Google Scholar]
  • 45.Kassebaum NJ, Smith AGC, Bernabe E, Fleming TD, Reynolds AE, Vos T, et al. Global, regional, and national prevalence, incidence, and disability-adjusted life years for oral conditions for 195 countries, 1990e2015: a systematic analysis for the global burden of diseases, injuries, and risk factors. J Dent Res 2017. April 1;96(4):380e7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Hoppo T, Sanz AF, Nason KS, et al. How much pharyngeal exposure is "normal"? Normative data for laryngopharyngeal reflux events using hypopharyngeal multichannel intraluminal impedance (HMII). J Gastrointest Surg. 2012; 16(1):16–24; discussion 24–5. 10.1007/s11605-011-1741-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Lee JS, Jung AR, Park JM, Park MJ, Lee YC, Eun YG. Comparison of Characteristics According to Reflux Type in Patients With Laryngopharyngeal Reflux. Clin Exp Otorhinolaryngol. 2018; 11(2):141–145. 10.21053/ceo.2017.00577 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Lechien JR, Bobin F, Muls V, et al. Validity and reliability of the reflux symptom score. Laryngoscope. 2019. 10.1002/lary.28017 [DOI] [PubMed] [Google Scholar]
  • 49.Habermann W, Schmid C, Neumann K, Devaney T, Hammer HF. Reflux symptom index and reflux finding score in otolaryngologic practice. J Voice. 2012; 26(3):e123–7. 10.1016/j.jvoice.2011.02.004 [DOI] [PubMed] [Google Scholar]
  • 50.Luo HN, Yang QM, Sheng Y, et al. Role of pepsin and pepsinogen: linking laryngopharyngeal reflux with otitis media with effusion in children. Laryngoscope. 2014; 124(7):E294–300. 10.1002/lary.24538 [DOI] [PubMed] [Google Scholar]
  • 51.Min HJ, Hong SC, Yang HS, Mun SK, Lee SY. Expression of CAIII and Hsp70 Is Increased the Mucous Membrane of the Posterior Commissure in Laryngopharyngeal Reflux Disease. Yonsei Med J. 2016; 57(2):469–74. 10.3349/ymj.2016.57.2.469 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Eckley CA, Sardinha LR, Rizzo LV. Salivary concentration of epidermal growth factor in adults with reflux laryngitis before and after treatment. Ann Otol Rhinol Laryngol. 2013; 122(7):440–4. 10.1177/000348941312200705 [DOI] [PubMed] [Google Scholar]
  • 53.Gill GA, Johnston N, Buda A, Pignatelli M, Pearson J, Dettmar PW, et al. Laryngeal epithelial defenses against laryngopharyngeal reflux: investigations of E-cadherin, carbonic anhydrase isoenzyme III, and pepsin. Ann Otol Rhinol Laryngol. 2005; 114(12):913–21. 10.1177/000348940511401204 [DOI] [PubMed] [Google Scholar]
  • 54.Samuels TL, Handler E, Syring ML, Pajewski NM, Blumin JH, Kerschner JE, et al. Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. Ann Otol Rhinol Laryngol. 2008; 117(9):688–95. 10.1177/000348940811700911 [DOI] [PubMed] [Google Scholar]
  • 55.O’Sullivan EA, Curzon ME, Roberts GJ, Milla PJ, Stringer MD. Gastroesophageal reflux in children and its relationship to erosion of primary and permanent teeth. Eur J Oral Sci 1998; 106: 765–9. 10.1046/j.0909-8836.1998.eos106302.x [DOI] [PubMed] [Google Scholar]
  • 56.Friesen LR, Bohaty B, Onikul R, et al. Is histologic esophagitis associated with dental erosion: a cross-sectional observational study? BMC Oral Health. 2017; 17(1):116 10.1186/s12903-017-0408-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Farahmand F, Sabbaghian M, Ghoudousi S, Seddighoraee N, Abbasi M. Gastroesophageal reflux disease and tooth erosion: a cross-sectional observational study. Gut Liver. 2013;7(3):278–281. 10.5009/gnl.2013.7.3.278 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Linnett V, Seow WK, Connor F, Shepherd R. Oral health of children with gastro-esophageal reflux disease: a controlled study. Aust Dent J 2002; 47: 156–62. 10.1111/j.1834-7819.2002.tb00321.x [DOI] [PubMed] [Google Scholar]
  • 59.Rapozo DC, Bernardazzi C, de Souza HS. Diet and microbiota in inflammatory bowel disease: The gut in disharmony. World J Gastroenterol. 2017; 23(12):2124–2140. 10.3748/wjg.v23.i12.2124 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Huck O, Mulhall H, Rubin G, et al. Akkermansia muciniphila reduces Porphyromonas gingivalis-induced inflammation and periodontalbone destruction. J Clin Periodontol. 2019. 10.1111/jcpe.13214 [DOI] [PubMed] [Google Scholar]
  • 61.Minty M, Canceil T, Serino M, Burcelin R, Tercé F, Blasco-Baque V. Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases. Rev Endocr Metab Disord. 2019. 10.1007/s11154-019-09526-8 [DOI] [PubMed] [Google Scholar]
  • 62.Inquimbert C, Bourgeois D, Giraudeau N, Tramini P, Viennot S, Dussart C, et al. Microbiota of interdental space of adolescents according to Risk of Caries: A cross-sectional study protocol. Contemp Clin Trials Commun. 2019; 16:100444 10.1016/j.conctc.2019.100444 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Loke C, Lee J, Sander S, Mei L, Farella M. Factors affecting intra-oral pH—a review. J Oral Rehabil. 2016; 43(10):778–85. 10.1111/joor.12429 [DOI] [PubMed] [Google Scholar]
  • 64.Yasutomi E, Hoshi N, Adachi S, et al. Proton Pump Inhibitors Increase the Susceptibility of Mice to Oral Infection with Enteropathogenic Bacteria. Dig Dis Sci. 2018; 63(4):881–889. 10.1007/s10620-017-4905-3 [DOI] [PubMed] [Google Scholar]
  • 65.Mishiro T, Oka K, Kuroki Y, et al. Oral microbiome alterations of healthy volunteers with proton pump inhibitor. J Gastroenterol Hepatol. 2018; 33(5):1059–1066. 10.1111/jgh.14040 [DOI] [PubMed] [Google Scholar]
  • 66.Wilder-Smith CH, Materna A, Martig L, Lussi A. Longitudinal study of gastroesophageal reflux and erosive tooth wear. BMC Gastroenterol. 2017; 17(1):113 10.1186/s12876-017-0670-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Gong H, Shi Y, Xiao X, Cao P, Wu C, Tao L, et al. Alterations of microbiota structure in the larynx relevant to laryngeal carcinoma. Sci Rep.2017. July 14;7(1):5507 10.1038/s41598-017-05576-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Ersin NK, Önçağ Ö, Tümgör G, Aydoğdu S and Hilmioğlu S. Oral and dental manifestations of gastroesophageal reflux dis- ease in children: a preliminary study. Pediatr Dent 2006; 28: 279–84. [PubMed] [Google Scholar]
  • 69.Bohmer CJ, Klinkenberg-Knol EC, Niezen-de Boer MC, Meuwissen PR, Meuwissen SG. Dental erosions and gastro-oesophageal reflux disease in institutionalized intellectually disabled individuals. Oral Dis 1997; 3: 272–5. 10.1111/j.1601-0825.1997.tb00053.x [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Giovanni Cammaroto

22 Jul 2020

PONE-D-20-20220

Laryngopharyngeal Reflux, Gastroesophageal Reflux and Dental Disorders: A Systematic Review.

PLOS ONE

Dear Dr. Lechien,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 05 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Giovanni Cammaroto

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please ensure you have included the full electronic search strategy for at least one database and uploaded it as an additional file.

3. We note that you have not included a statement in the Competing Interests or Financial Disclosure section.

We also note that one or more of the authors are employed by a commercial company: Edwards-Realty Enterprise

a. Please provide an complete Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

b. Please also provide a complete Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.  

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

c. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is an interesting review regarding laryngopharyngeal reflux, gastroesophageal reflux and dental disorders. No reviews about this specific topic have been published so far. Besides, the study is well conducted and all aspects concerning the topic are analyzed.

Recently, in patients with laryngopharyngeal reflux pepsin has also been identified in tears, please mention this possibility.

Is there any evidence regarding reflux treatment and dental conditions? If they exist, they should be mentioned.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Aug 14;15(8):e0237581. doi: 10.1371/journal.pone.0237581.r002

Author response to Decision Letter 0


27 Jul 2020

PLOS ONE

Mons, July, 2020

Dear Professor Cammaroto,

I’m sending the revised Systematic Review entitled: “Laryngopharyngeal Reflux, Gastroesophageal Reflux and Dental Disorders: A Systematic Review." (by Lechien et al.).

I undersigned, Jérôme R. Lechien, certify on behalf of all co-authors that the work has not been published previously or submitted elsewhere for review. Any author has financial interest in the subject under discussion. All authors have read and approved the manuscript. Would you be so kind to consider the present manuscript and send us the Reviewer’s comments.

We considered the comments of the reviewer and the editor.

Reviewer #1: This is an interesting review regarding laryngopharyngeal reflux, gastroesophageal reflux and dental disorders. No reviews about this specific topic have been published so far. Besides, the study is well conducted and all aspects concerning the topic are analyzed.

Thank you.

Recently, in patients with laryngopharyngeal reflux pepsin has also been identified in tears, please mention this possibility.

We modified the paragraph in the introduction: introduction, line 6 : « Thus, pepsin has been identified in the laryngeal [5], hypopharyngeal [6], oral [7], nasal [7], tears [8], and Eustachian mucosa as well as in the secretion of chronic rhinosinusites9 and chronic media otitis [10]. »

Is there any evidence regarding reflux treatment and dental conditions? If they exist, they should be mentioned.

There is one study, but the data of this study (Wilder-Smith et a., 2017) overlapped those of another study (Wilder-Smith, 2015).

We included these findings in the discussion : last paragraph of the discussion : « Note that, to date, only one study investigated the dental health of GERD patients throughout a PPI clinical course. Wilder-Smith et al. found that erosive tooth wear did not progress over the 12-month PPI course [66]. »

Best regards,

Jérôme R. LECHIEN, M.D., Ph.D., M.S.

Head and Neck surgery, Laboratory of Anatomy and Cell Biology, Faculty of Medicine, University of Mons (UMONS), Avenue du Champ de mars, 6, B7000 Mons, Belgium, Jerome.Lechien@umons.ac.be

Telephone: +32 65 37 35 84

Fax: +32 65 37 31 42

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Giovanni Cammaroto

30 Jul 2020

Laryngopharyngeal Reflux, Gastroesophageal Reflux and Dental Disorders: A Systematic Review.

PONE-D-20-20220R1

Dear Dr. Lechien,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Giovanni Cammaroto

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Giovanni Cammaroto

4 Aug 2020

PONE-D-20-20220R1

Laryngopharyngeal Reflux, Gastroesophageal Reflux and Dental Disorders: A Systematic Review.

Dear Dr. Lechien:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Giovanni Cammaroto

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PRISMA 2009 checklist.

    (DOC)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES